CAMG
CWA Asset Management Group’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Sell |
899
-536
| -37% | -$217K | 0.02% | 499 |
|
|
2025
Q1 | $714K | Buy |
1,435
+59
| +4% | +$29.4K | 0.03% | 361 |
|
|
2024
Q4 | $716K | Sell |
1,376
-388
| -22% | -$202K | 0.04% | 322 |
|
|
2024
Q3 | $1.09M | Buy |
+1,764
| New | +$1.09M | 0.06% | 233 |
|
|
2024
Q1 | $919K | Buy |
1,582
+269
| +20% | +$156K | 0.06% | 236 |
|
|
2023
Q4 | $697K | Buy |
1,313
+431
| +49% | +$229K | 0.05% | 205 |
|
|
2023
Q3 | $447K | Buy |
882
+19
| +2% | +$9.62K | 0.03% | 233 |
|
|
2023
Q2 | $450K | Sell |
863
-119
| -12% | -$62.1K | 0.03% | 231 |
|
|
2023
Q1 | $566K | Buy |
982
+59
| +6% | +$34K | 0.04% | 184 |
|
|
2022
Q4 | $508K | Buy |
923
+93
| +11% | +$51.2K | 0.04% | 191 |
|
|
2022
Q3 | $421K | Sell |
830
-22
| -3% | -$11.2K | 0.04% | 194 |
|
|
2022
Q2 | $463K | Sell |
852
-30
| -3% | -$16.3K | 0.04% | 182 |
|
|
2022
Q1 | $521K | Buy |
882
+216
| +32% | +$128K | 0.04% | 183 |
|
|
2021
Q4 | $444K | Buy |
666
+13
| +2% | +$8.67K | 0.03% | 195 |
|
|
2021
Q3 | $373K | Buy |
653
+34
| +5% | +$19.4K | 0.03% | 205 |
|
|
2021
Q2 | $315K | Sell |
619
-5
| -0.8% | -$2.54K | 0.03% | 213 |
|
|
2021
Q1 | $285K | Hold |
624
| – | – | 0.03% | 219 |
|
|
2020
Q4 | $291K | Buy |
624
+13
| +2% | +$6.06K | 0.03% | 209 |
|
|
2020
Q3 | $270K | Buy |
611
+23
| +4% | +$10.2K | 0.04% | 185 |
|
|
2020
Q2 | $213K | Buy |
+588
| New | +$213K | 0.04% | 190 |
|
|
2020
Q1 | – | Sell |
-626
| Closed | -$203K | – | 266 |
|
|
2019
Q4 | $203K | Buy |
+626
| New | +$203K | 0.03% | 218 |
|